pdufa.bio
CalendarReadoutsDevicesDecisionsApprovals/yrTrial oddsLearnResearchMethodology
Home › Readouts › November 2027

November 2027 clinical-trial readouts

trial-readout estimates for November 2027, each row linked to its primary source. Readout dates are estimated primary-completion windows from ClinicalTrials.gov and shift.
← October 2027December 2027 →
21 readouts
CRNX · Nov 2027 (est.)
Atumelnant — Congenital Adrenal Hyperplasia
CHRS · Nov 2027 (est.)
CHS-1420 — Ovarian Cancer Stage IV
CRIS · Nov 2027 (est.)
chondrocyte-alginate gel suspension — Chronic Lymphocytic Leukemia
CRVS · Nov 2027 (est.)
Soquelitinib — Peripheral T-Cell Lymphoma, Not Otherwise Specified
MPLT · Nov 2027 (est.)
ML-007C-MA — Autism Spectrum Disorder
NBIX · Nov 2027 (est.)
NBI-1065845 — Schizophrenia
ONC · Nov 2027 (est.)
BGB-3111 — B-cell Malignancies
RNAC · Nov 2027 (est.)
Decartes-08 — Antisynthetase Syndrome
RYTM · Nov 2027 (est.)
Setmelanotide — Hypothalamic Obesity
SABS · Nov 2027 (est.)
SAB-142 — Type 1 Diabetes
SYK · Nov 2027 (est.)
Ropivacaine — Breast Cancer
UTHR · Nov 2027 (est.)
Inhaled Treprostinil — Progressive Pulmonary Fibrosis
VERA · Nov 2027 (est.)
Atacicept — pMN
ANRO · Nov 2027 (est.)
ALTO-207 — Treatment-resistant Depression (TRD)
AURA · Nov 2027 (est.)
Bel-sar — Choroidal Melanoma
CGEN · Nov 2027 (est.)
COM701 — Neoplasm
REGN · Nov 2027 (est.)
Cemdisiran — Age-related Macular Degeneration (AMD)
MYGN · Nov 2027 (est.)
Niraparib — Solid Tumor
SRPT · Nov 2027 (est.)
SRP-1005 — Huntington's Disease
ARVN · Nov 2027 (est.)
ARV-471 — KRAS G12D Mutation
CTMX · Nov 2027 (est.)
CX-072 — Solid Tumor, Adult
Looking for an approval probability for these? We deliberately don't publish one — here's why, and what we show instead (verified history + base rates).